
Abipime T 250mg/31.25mg Injection
Marketer
Abiz Pharma
Salt Composition
Cefepime (250mg) + Tazobactum (31.25mg)
Overview Abipime T 250mg/31.25mg Injection
Bipime-T 250mg/31.25mg injection combines two antibiotics to combat diverse bacterial infections. Its mechanism involves inhibiting microbial growth. Administration must be under a doctor's direct supervision; missed doses should be avoided, and the full treatment course completed regardless of symptom improvement. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rashes), and localized injection site reactions (redness, swelling, pain), typically resolving spontaneously. Worsening side effects necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, respiratory distress) demand prompt medical help. Prior to use, inform your physician of all other medications, and pregnant or nursing individuals should seek medical advice before starting treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs.
Uses of Abipime T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Abipime T 250mg/31.25mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Abipime T 250mg/31.25mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Abipime T 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Abipime T 250mg/31.25mg Injection works:
Abipime T Injection (250mg/31.25mg) combines the antibiotic cefepime with the beta-lactamase inhibitor tazobactam. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam counteracts bacterial enzymes that would otherwise deactivate cefepime, thus broadening cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Use of Abipime T 250mg/31.25mg Injection with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Abipime T (250mg/31.25mg) is typically deemed safe for use in pregnancy. Preclinical trials using animal models revealed minimal or no harm to the fetus; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Abipime T 250mg/31.25mg Injection poses minimal risk during lactation. Research in humans indicates negligible transfer into breast milk, posing no discernible threat to the infant.
DrivingUNSAFE
Following administration of Abipime T 250mg/31.25mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
The injectable medication, Abipime T 250mg/31.25mg, requires careful administration for individuals with impaired kidney function. Dosage modification of Abipime T 250mg/31.25mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Abipime T 250mg/31.25mg Injection in individuals with hepatic impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary for this patient population. However, physician consultation is advised.
What if you forget to take Abipime T 250mg/31.25mg Injection :
Should you forget a dose of Abipime T 250mg/31.25mg Injection, seek medical advice.
Facts to Know About Abipime T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Addiction potential | None. |
| Medication Classification | Agents against infection |
